It was shown that overexpression of MGMT and promoter methylation made tumor cells more effective in resisting TMZ drug toxicity, suggesting a close relationship between MGMT and tumor drug chemoresistance and a direct relationship with patient prognosis (21, 56–58). This evidence concerns the gene MGMT and neoplasm.